Abstract:Background: Ovarian cancer (OC) lacks specific symptoms and screening methods, and most patients are diagnosed at an advanced stage with worse prognosis. Currently, the major treatment approaches for advanced epithelial ovarian carcinoma (AEOC) have been primary debulking surgery (PDS) followed by platinum-based chemotherapy, and neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS). Serum CA125 has been widely used as an indicator for OC diagnosis and management. It is generally believe… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.